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Abstract
Background: Osteoarthritis (OA) is the most common cause of disability in the elderly. Clinical frailty is associated with
high mortality, but few studies have explored the relationship between OA and frailty.
The objective of this study was to consider the association between OA and frailty/pre-frailty in an elderly population
comprised of six European cohorts participating in the EPOSA project.
Methods: Longitudinal study using baseline data and first follow-up waves, from EPOSA; 2,455 individuals aged 65-85
years were recruited from pre-existing population-based cohorts in Germany, Italy, the Netherlands, Spain, Sweden and
the United Kingdom. Data were collected on clinical OA at any site (hand, knee or hip), based on the clinical
classification criteria developed by the American College of Rheumatology (ACR). Frailty was defined according
to Fried's criteria. The covariates considered were age, gender, educational level, obesity and country. We used
multinomial logistic regression to analyse the associations between OA, frailty/pre-frailty and other covariates.
Results: The overall prevalence of clinical OA at any site was 30.4 % (95 % CI:28.6-32.2); frailty was present in 10.2 %
(95 % CI:9.0-11.4) and pre-frailty in 51.0 % (95 % CI:49.0-53.0). The odds of frailty was 2.96 (95 % CI:2.11-4.16)
and pre-frailty 1.54 (95 % CI:1.24-1.91) as high among OA individuals than those without OA. The association
remained when Knee OA, hip OA or hand OA were considered separately, and was stronger in those with
increasing number of joints.
Conclusions: Clinical OA is associated with frailty and pre-frailty in older adults in European countries. This
association might be considered when designing appropriate intervention strategies for OA management.
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Background
Osteoarthritis (OA) is thought to be the most prevalent
chronic joint disease in the world and one of the most
common sources of pain and disability in the elderly [1].
Half of the world's population aged 65 and older suffer
from OA, and 80 % of people with symptomatic OA
have limitations in movement, while 25 % cannot
perform their normal daily activities [2]. The prevalence
of OA varies widely depending on the whether the
criteria adopted are based on self-report, clinical report
and/or radiologic imaging [3–8]. It clearly increases with
age, and may even triple in frequency in persons age 70
or over and in those with obesity [3, 4].
Because OA occurs in older adults who also have age-
related changes in muscle, bone, fat and the nervous
system, it is likely that a more general and systemic
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approach will be needed to better understand the link
between aging and OA [9].
Frailty is a physiological state characterized by the
deregulation of multiple physiologic systems of an aging
organism determining the loss of homeostatic capacity,
which exposes the elderly to disability, diseases, and
finally death [10–12]. The clinical phenotype of frailty
manifests as multi-system pathologies characterized by
low physical activity, global weakness with low muscle
strength, exhaustion, overall slowness and loss of weight
[10, 11]. The worldwide prevalence of frailty ranges
between 6.9 % and 42.6 % [10, 13–17]. There is also a
documented heterogeneity in the quality of aging
among different geographic areas, which suggests the
need for a frailty classification approach providing
population-specific results [15]. Pre-frailty occurs at an
earlier stage of the frailty spectrum and is associated
with the later development of frailty. Thus, pre-frailty
might be a better target of screening and implementa-
tion of early interventions. [12, 17]
Frailty as a geriatric syndrome it has its pathophysio-
logical substrate in sarcopenia [18]; it involves loss of
functionality and is a prognostic factor for disability [16].
OA is not purely a mechanical problem. In addition to
age, genetic and nutritional factors are also important;
obesity predisposes individuals to OA both for mechan-
ical reasons and through inflammatory or metabolic
mechanisms [4, 8]. Some studies have found a relation-
ship between OA and frailty, using different diagnostic
criteria in both processes [19–21] but, to our knowledge,
in Europe there are no population-based studies that
relate the two concepts. The EPOSA project is a popula-
tion-based study using pre-harmonized data across six
European countries on older community-dwelling persons
aged 65 to 85 years, and it includes clinical data on OA
and frailty [22]. This project provides an opportunity for
in-depth study of the association between OA and frailty
across Europe in an elderly population.
Accordingly, the objective of this study was to con-
sider the association between OA and frailty/pre-frailty
in an elderly population comprised of six European co-
horts participating in the EPOSA project.
Methods
Study design and participants
The EPOSA project involves six cohort studies, each
performed in a different country: Germany (The study
on Activity and Function in the Elderly in Ulm, ActiFE-
Ulm), the United Kingdom (UK) (Hertfordshire Cohort
Study, HCS), the Netherlands (Longitudinal Aging Study
Amsterdam, LASA), Italy (Godega di Sant’Urbano,
Veneto Region), Spain (Ageing in Peñagrande), and
Sweden (Swedish Twin Register). Random samples from
these population-based cohorts were included. In each
cohort, around 750 potential participants were contacted
with the aim of recruiting 500 participants. In Italy, a
new sample was drawn, with recruitment procedures
and age/sex-distributions similar to those in the other
studies. A total of 2,942 respondents (response rate
ranging from 64.6 % to 82.2 %, averaging 72.8 %) were
included in the EPOSA baseline study. The overall age
range was 65-85 years (with oversampling of the oldest
respondents) in all cohorts except for the UK, in which
the age range was 71-79 years.
A detailed description of the study design and data
collection of the EPOSA study is described elsewhere
[22]. All participants completed an informed consent.
For all six countries, the study design and procedures
were approved by the Medical Ethics committee of the
respective centers (Germany: Ethical Committee of Ulm
University; the Netherlands: Medical Ethical Commit-
tee of the VU University Medical Center; Spain: Ethic
Committee for Clinical Research of University Hospital
La Paz of Madrid; Sweden: Ethics Board of Karolinska
Institutet; UK: The Hertfordshire Research Ethics
Committee; Italy: Comitatio etico ULSS7).
It is a longitudinal study in which all the variables
were collected primarily from March to November 2011,
except for frailty which was collected one year later
(between March and November 2012). The study popu-
lation for the present analysis was made up of 2,455
individuals who participated in the baseline and the
follow-up waves. 487 baseline participants (16.6 %) could
not be included because they had died, were untraceable,
or declined to participate one year later. The proportion
of people aged 80-85 and of women in this group of
non-respondents was higher than in participants (28.1 %
vs 15.4 %, for age and 57.5 % vs 50.8 % for sex, respect-
ively). The proportion of obese people in both samples
was similar. A standardized questionnaire was applied
and a clinical examination was performed. Participants
were visited in their homes by trained research nurses,
except for Italy and Spain, where participants were
examined in a health care centre, and only disabled
persons were visited in their home.
Study variables/ measures
Data were collected on the following variables:
Clinical osteoarthritis
Algorithms for clinical OA were developed based on the
clinical classification criteria developed by the American
College of Rheumatology (ACR) [23]. Algorithms were
specified both for site-specific OA (knee, hip and hand,
respectively) and Clinical OA at any site (any of these
three joints). The clinical diagnosis of knee OA was
based on both history and physical examination: pain in
the knee was evaluated by the Western Ontario and
Castell et al. BMC Musculoskeletal Disorders  (2015) 16:359 Page 2 of 8
McMaster Universities OA Index (WOMAC) pain
subscale score [24], plus any three of: age 50 or over,
morning stiffness lasting <30 min, evaluated by the
WOMAC stiffness subscale (score from ‘mild’ to
‘extreme’); crepitus on active motion in at least one side;
bony tenderness in at least one side; bony enlargement
in at least one side, and no palpable warmth of synovium
in both knees. The clinical diagnosis of hip OA was
based on both history and physical examination: pain in
the hip was evaluated by the WOMAC pain subscale
score, plus all of: pain associated with hip internal rota-
tion in at least one side; morning stiffness lasting
<60 min, evaluated by the WOMAC stiffness subscale
(score from ‘mild’ to ‘extreme’); and age 50 or over. The
clinical diagnosis of hand OA was based on both history
and physical examination: pain, aching or stiffness of the
hand was evaluated by the Australian/Canadian OA
Hand Index (AUSCAN) pain and stiffness subscale [25];
plus any two of: hard tissue enlargement of two or more
of the 2nd and 3rd distal interphalangeal (DIPs), 2nd
and 3rd proximal interphalangeal (PIPs), 1st carpometa-
carpal (CMC) joints of at least one hand; hard tissue
enlargement of two or more DIPs of at least one hand;
deformity of at least one of the 2nd and 3rd DIPs, 2nd
and 3rd PIPs, 1st CMC joints of at least one hand. Swell-
ing of the metacarpophalangeal (MCP) joints, which is
also included in the ACR classification criteria as a
control to exclude rheumatic arthritis, was only mea-
sured in the UK and Germany. The categorical variable
Clinical OA-number of sites describes the number of
joints involved, from 0 a 3 (knee, hip and/or hand)
Frailty was measured based on the five criteria
proposed by Fried [9], with some adaptation as follows:
1) Unintentional weight loss (Shrinking) of ≥5 % in the
last year; 2) Low energy (Exhaustion) based on questions
from the Centre for Epidemiologic Studies Depression
Scale (CES-D); 3) Weakness: Grip strength in the domin-
ant hand measured with a dynamometer (JamarR) and
adjusted for body mass index (BMI); 4) Slowness: Calcu-
lated after walking three meters, adjusted for sex and
height. Participants were asked to “walk to the other end
of the course as quickly as you can, but do not run” and
were timed using a stopwatch. In the UK, the instruction
was to “walk to the other end of the course at your usual
speed, just as if you were walking down the street to go
to a shop”. In Germany, 361 of the participants were
measured using a GAITRite® walkway system and were
standardised using a stopwatch. Individuals included in
the worst quintile in each country were considered to be
slow. 5) Low physical activity: Kilocalories (kcal) expended
per week were calculated based on the Longitudinal
Ageing Study Amsterdam (LASA) Physical Activity
Questionnaire (LAPAQ) [26], using self-reports about the
frequency and duration of walking, cycling, gardening and
engaging in sports. The cut-off points used in this case
were the worst quintile in the EPOSA sample.
Persons who met at least three criteria were consid-
ered to be frail, those who met one or two criteria
were prefrail, and those with none were considered
non-frail. Accordingly, the variable frailty was divided
into three categories.
Potential co-variables
Demographic covariates such as age, gender and edu-
cation level were collected. Education was measured by
asking for the highest level of education completed and
was categorized into “elementary school not completed”,
“elementary school completed”, “vocational education/
general secondary education”, and “college or university
education”.
Health covariates: BMI was calculated as weight in
kilograms divided by height in squared meters. Obesity
was defined as BMI of 30 kg/m2 or higher. Number of
chronic conditions was measured through self-reported
presence of the following chronic diseases or symptoms
that lasted for at least 3 months or diseases for which
the respondent had been treated or monitored by a
physician: chronic non-specific lung disease, cardiovascu-
lar diseases, peripheral artery diseases, stroke, diabetes,
cancer, and osteoporosis. Comorbidity was evaluated as
the number of diseases, or defined as the occurrence of
two or more coexisting conditions.
Country covariate
Data from the cohorts of Germany, Italy, the Netherlands,
Spain, Sweden and the United Kingdom were collected.
Statistical methods
As age distribution and gender split varied between the
cohorts of different countries, a weighting variable was
created for each individual within each country. The
weights were calculated per sex and per 5-year age
groups, using the formula: W = Pexp/Pobs, where Pobs
is the observed proportion of persons in a specific age/
gender category in the cohort (n1/n), and Pexp is the
expected proportion of persons in a specific age/gender
category in the population (N1/N), taking the European
Standard Population in 2010 as the reference population
[22]. This technique allowed direct comparisons of the
variables across countries.
A descriptive analysis was performed. For the con-
tinuous variables such as age, the mean and standard
deviation were calculated. Categorical variables were
expressed as absolute frequencies and their 95 %
confidence intervals (95 % CI).
We calculated the frequency of frailty and OA in the
study population and made a descriptive analysis of
frailty by demographic (age, gender and educational
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level) and health-related variables (obesity, comorbidity,
and OA). Differences among countries were assessed
using Kruskal Wallis for age and the chi-squared test for
categorical variables.
The association between OA and frailty was summa-
rized with odds ratios (OR) and their 95 % confidence
interval (CI) obtained from logistic regression. Multi-
variate analyses were conducted using the variable
frailty with three categories (no frailty as reference vari-
able, pre-frailty and frailty), as the dependent variable
(multinomial logistic regression) and OA as the main
independent variable, introducing in the model the co-
variables that were associated with frailty at p < 0.10 in
a bivariate analysis.
We conducted five regression analyses, using the
previously described measures of OA (clinical OA at
any site, knee OA, hip OA, hand OA and clinical OA-
number of sites) in each analysis. All analyses were
performed using SPSS for Windows version 19.0.
Results
A total of 2,455 individuals participated in the baseline
and the follow-up waves. The mean age of participants
in the pooled data across all countries was 74.0 years
(SD: 5.0), 50.8 % were women, 42.1 % had no more than
elementary school education, 28.6 % were obese, and
27.5 % presented comorbidity. Clear differences were
observed between countries with regard to educational
attainment. Over 70 % of participants in the cohorts of
Italy and Spain had at most a primary school education,
whereas this percentage was 20.9 % in the UK, 21.9 % in
Sweden and 24.4 % in the Netherlands. In Germany, half
of the participants had reached or exceeded the level of
secondary school education (Table 1).
The overall prevalence of clinical OA at any site was
30.4 %; 16.3 % had OA of the hand, 5.9 % of the hip, and
19 % of the knee (Table 2). The highest levels of clinical
OA at any site were found in Italy (42.3 %), which also
had the highest figures for OA of the hand, knee and
hip. Germany had the lowest levels, with 19.7 % of
clinical OA at any site. Women had a higher frequency
of OA than men in all age groups, both when analysed
overall and by each OA site (Fig. 1).
Frailty was present in 10.2 % of the population,
ranging across countries from a prevalence of 5.6 % in
Germany and Sweden to 15.4 % in the UK (p < 0.001).
The overall prevalence of pre-frailty was 51.0 % (Table 2).
Both frailty and pre-frailty were higher in women and
increased with age in both sexes, with frailty reaching
26.1 % in women aged 80 and over (Fig. 1).
The bivariate analysis showed that all covariables were
associated with frailty or pre-frailty at p <0.05.
Table 3 shows the association between OA and pre-
frailty and frailty. The crude OR of OA in prefrail and
frail people was 1.74 and 3.69, respectively. After adjust-
ment for all the study variables, the OR for OA was
reduced to 1.54 for pre-frailty and to 2.96 for frailty. It
can be seen that comorbidity and obesity as co-variables
in this fully adjusted model are independently associated
with both pre-frailty and frailty.
Table 4 shows the fully adjusted OR of the differ-
ent OA variables used. After adjusting for the
confounding variables, including country, the pres-
ence of OA was associated with pre-frailty (OR:1.54;
95 % CI:1.24-1.91) and, more strongly, with frailty
(OR:2.96; 95 % CI:2.11-4.16). This association was
maintained for each of the joints analysed, and the
odds of frailty were four times higher when the hip
was the affected joint (OR:4.41; 95 % CI:1.41-13.82).
The strength of the association increased with the
number of affected joints; when OA was present at
the same time in all three joints analysed, the odds
of pre-frailty were three times higher (OR 2.26; 95 %
CI:1.28-8.32) and the odds of frailty were over eight
times higher (OR: 8.95; 95 % CI:2.83-28.39).
Discussion
This study suggests a strong association between OA
and frailty that remains after adjusting for socio-
demographic and health-related variables and that is
Table 1 Characteristics of participants by country
Overall Country
N = 2455 GER NL IT SP SW UK
N = 336 N = 483 N = 319 N = 457 N = 450 N = 410
Age (years)a Mean (SD) 74.0 ± 5.0 74.1 ± 4.9 74.9 ± 5.6 72.8 ± 5.0 74.6 ± 5.4 71.9 ± 4.9 75.2 ± 2.6
% [95% CI] % [95% CI] % [95% CI] % [95% CI] % [95% CI] % [95% CI] % [95% CI]
Gender femalea 50.8(48.8-52.8) 39.6(34.4-44.8) 54.9(50.5-59.3) 50.8(45.3-56.3) 47.5(42.9-52.1) 58.7(54.2-63.2) 50.2(45.4-55.0)
Education (≤ elementary) 42.1(40.1-44.1) 48.4(43.1-53.7) 24.4(20.6-28.2) 74.9(70.1-79.7) 71.1(66.9-75.3) 21.9(18.1-25.7) 20.9(17.0-24.8)
Obesity (BMI≥ 30) 28.6(26.8-30.4) 45.3(40.0-50.6) 26.4(22.5-30.3) 25.4(20.6-30.2) 34.4(30.0-38.8) 16.1(12.7-19.5) 29.0(24.6-33.4)
Comorbidity (≥2 diseases) 27.5(25.7-29.3) 27.4(22.6-32.2) 23.8(20.0-27.6) 33.7(28.5-38.9) 33.2(28.9-37.5) 20.8(17.0-24.6) 28.9(24.5-33.3)
Weighted data to the European standard population in 2010 excepta
P-value <0.001 in all variables between countries
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maintained when analysing different sites separately
(knee, hip, hand). The odds of pre-frailty and frailty
were 1.54 and 2.96 times higher among OA than
non-OA patients.
Recent publications have found an independent as-
sociation between hip OA and frailty or pre-frailty in
men aged 65 and over [27] and knee OA has been
shown to be associated with a greater prevalence and
risk of developing frailty [20]. Other studies have
found a relationship between frailty and OA measured
with subjective criteria [15, 21]. These results suggest
common pathophysiological mechanisms underlying
both conditions. Certain inflammatory cytokines (IL1,
IL-6 and TNFalpha) that are involved in the frailty
cycle [18, 28, 29] are increased in OA cartilage as
opposed to normal cartilage. The response to growth
factors such as IGF1 declines markedly, thus inhibiting
maintenance of normal cartilage and promoting the devel-
opment of OA [18, 28].
The high prevalence of OA among the elderly is well
known [3–7]. In our study, 30.4 % of cases had OA in
one or more of the joints studied. The prevalence of OA
at any site was very high in Italy (42.3 %) and was low in
Germany (19.7 %), and these differences were main-
tained regardless of the joint affected. Although there
are demographic differences across countries such as
age, sex, educational level, the variability in prevalence
rates may be influenced by other factors as climate,
Table 2 Frequency of OA and frailty status by country (weighted dataa)
Overall GER NL IT SP SW UK % p**
% [95 % CI] % [95 % CI] % [95 % CI] % [95 % CI] % [95 % CI] % [95 % CI] [95 % CI]
Clinical OA at any site 30.4(28.6-32.2) 19.7(15.4-24.0) 26.0(22.1-29.9) 42.3(36.9-47.7) 34.7(30.3-39.1) 32.7(28.4-37.0) 26.7(22.4-31.0) <0.001
Hand OA 16.3(14.8-17.8) 11.8(8.4-15.2) 11.6(8.7-14.5) 21.2(16.7-25.7) 19.5(15.9-23.1) 19.2(15.6-22.8) 14.5(11.1-17.9) <0.001
Hip OA 5.9(5.0-6.8) 0.7(0.3-1.6) 6.9(4.6-9.2) 13.8(10.0-17.6) 4.7(2.8-6.6) 4.6(2.7-6.5) 5.0(2.9-7.1) <0.001
Knee OA 19.0(17.4-20.6) 10.4(7.1-13.7) 18.3(14.9-21.7) 25.4(20.6-30.2) 23.5(19.6-27.4) 19.7(16.0-23.4) 15.1(11.6-18.6) <0.001
Frail 10.2(9.0-11.4) 5.6(3.1-8.1) 10.9(8.1-13.7) 12.2(8.6-15.8) 12.6(9.6-15.6) 5.6(3.5-7.7) 15.4(11.9-18.9) <0.001
Pre-frail 51.0(49.0-53.0) 48.4(43.1-53.7) 47.1(42.6-51.6) 61.9(56.6-67.2) 56.1(51.5-60.7) 42.2(37.6-46.8) 54.8(50.0-59.6) <0.001
Non-frail 38.8(36.9-40.7) 46.1(40.8-51.4) 42.1(37.7-46.5) 26.0(21.2-30.8) 31.4(27.1-35.7) 52.2(47.6-56.8) 29.8(25.4-34.2) <0.001
aThe weighted data were derived from the European standard population in 2010
**P-value <0.001 in all variables between countries
MALE FEMALE
P<0.01P<0.01
%
%%
%
Fig. 1 Prevalence of OA and frailty by age and sex in the overall EPOSA sample (n = 2455)
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health care, lifestyle or environmental factors [22, 30].
The findings of other studies in the developed world are
consistent with ours. In the Rotterdam Study the preva-
lence of OA based on clinical criteria was 16.2 % in men
and 20.4 % in women aged 75-84 years [31]. The
Johnston County study reported a frequency of 47 %
in men and 49.2 % in women aged 70-74 years [32].
The prevalence of frailty is high in the elderly and will
increase in the future due to the progressive ageing of
the population. Our results show that the overall preva-
lence of frailty is 10.2 % and of pre-frailty is 51.0 %,
which is consistent with other population-based studies
of similar characteristics conducted in Europe [14, 21].
The Survey of Health, Ageing and Retirement in Europe
(SHARE) [20], which compared frailty across 10 European
countries, found a much higher prevalence in the
Mediterranean countries (Italy and Spain) and a lower
prevalence in Nordic countries like Sweden. Because
of the high frequency and the earlier stage of the
frailty spectrum, the prefrail constitute a target popu-
lation requiring action from the health and social
services [33, 34].
Obesity is strongly associated with OA and frailty in older
people, and in the presence of the three conditions there is
a higher risk of functional limitation [19, 27, 35–37]. In our
study, obese individuals had a higher risk of being prefrail
and frail, as we can see in Table 3. It is important to realize
that obesity acts not only as a local biomechanical factor,
but as a systemic component [4] and its influence increases
with age: Body composition changes with age, even if body
mass index (BMI) does not vary, with an increased propor-
tion of fat mass and decrease in lean mass. It is now appre-
ciated that these age-related changes occurring in tissues
besides articular cartilage may contribute to the develop-
ment of OA [1]. However, these changes are much more
intense in the presence of obesity, frailty and/or OA and, as
noted by several authors, may be due to the development
of insulin resistance and the maintenance of chronic
inflammatory processes over time [8, 10, 14]. Sarcopenic
obesity, a condition in which lean body mass is lost while
fat mass may be preserved or even increased [17] has a
stronger association with knee OA than non-sarcopenic
obesity, indicating the importance of the systemic
metabolic effect of obesity in OA [29].
This study has some limitations. Although all partici-
pants were recruited from pre-existing community-
based cohorts of older individuals, the cohorts may not
be representative of their respective countries to the
same extend, due to differential attrition. However, these
differences may allow hypothesis generation regarding
the association between OA and frailty. The non-
participation in the 1-year follow-up of 487 baseline
individuals may influence the results, but given the
higher proportion of women and older individuals,
which are variables associated with a higher prevalence
of frailty and OA, the results presented would likely have
been stronger had we been able to include the non-
participants. Another limitation is that the involve-
ment of multiple research centres meant that data
collection methods might vary by study site. However,
all questionnaires and protocols for examination were
undertaken by one team to minimize such problems
and OA was diagnosed according to clinical criteria
and following a similar methodology in all the partici-
pating cohorts. Finally, although the study design is
longitudinal, given that the main variables (OA and
frailty) are chronic processes, and that the period
between baseline and the follow-up wave was very
short, we cannot assume the temporal direction of
Table 3 Association between Osteoarthritis (OA) and pre-frailty/frailty. Multinomial regression
PRE-FRAILTY FRAILTY
Osteoarthritis (OA) (crude) 1.74[1.42-2.12] 3.69[2.74-4.97]
OA adjusted for age and sex 1.78[1.45-2.19] 3.91[2.83-5.40]
OA adjusted for age, sex, education & country 1.68[1.36-2.08] 3.65[2.63-5.08]
OA adjusted for age, sex, education, country & comorbidity 1.60[1.30-1.99] 3.26[2.34-4.56]
OA adjusted for age, sex, education, country, comorbidity & obesity 1.54[1.24-1.91] 2.96[2.11-4.16]
Values expressed as Odds Ratios. OR (95 % CIs)
Reference category: non-osteoarthritis
Table 4 Fully adjusted association between Osteoarthritis (OA)
in different sites and pre-frailty/frailty status (five multinomial
regressions)a
PRE-FRAILTY FRAILTY
CLINICAL OA AT ANY SITEb 1.54 [1.24-1.91] 2.96 [2.11-4.16]
KNEE OAc 1.43 [1.04-1.98] 2.08 [1.25-3.46]
HIP OAc 1.95 [0.86-4.42] 4.41 [1.41-13.82]
HAND OAc 1.50 [1.06-2.12] 2.57 [1.46-4.55]
CLINICAL OA-NUMBER OF SITES
OA 1 SITEb 1.45 [1.14-1.85] 2.47 [1.68-3.63]
OA 2 SITESb 1.73 [1.16-2.57] 4.18 [2.42-7.22]
OA 3 SITESb 2.26 [1.28-8.32] 8.95 [2.83-28.39]
Values expressed as Odds Ratios. OR (95 % CIs)
aOR Adjusted for age, gender, education, country, comorbidity and BMI
bReference category: non-OA at any site
cReference category: non-OA at that site
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causality in the association detected. Other longitu-
dinal studies over a longer time period are needed to
assess the relationship between the incidence of frailty
or pre-frailty and the presence of OA.
Due to the high prevalence of OA and frailty in persons
aged 65 and over, the strong association between the two
processes and the fact that frailty has been considered as a
predictor of mid-term mortality in individuals with OA
[35], several authors have recommended preventive and
therapeutic interventions at the community level. These
include, firstly, the early detection of frailty as an import-
ant measure of overall health status in the elderly [27].
The frailty score proposed by Fried et al. has biological
validity and is easy and inexpensive to measure [14]. Fur-
thermore, OA seems to be associated with worsening of
and/or lower recovery from frailty [33]. Thus, we should
encourage the use of this scale in the screening of older
persons, especially those age 75 and over [38].
Another intervention may be to promote or prescribe
appropriate exercise. The practice of regular physical
activity that includes both aerobic and resistance exer-
cises tailored to each individual's needs is probably the
most efficient intervention to prevent frailty and to delay
disability and the adverse events associated with obesity
and frailty [34, 39, 40]. Health benefits can be obtained
at any point in the evolution of OA and frailty [40].
Finally, weight loss is a priority in the long-term man-
agement of obese individuals with OA. Not only does this
help lessen joint overload, it also results in decreased fat
mass and a proportional increase in lean mass which leads
to functional improvement [29]. The Mediterranean diet,
rich in olive oil, fruits and vegetables, and with a predom-
inance of polyunsaturated fatty acids, also contributes to
improved functionality and quality of life in individuals
with osteoarticular pathology [41].
Conclusion
The prevalence of both OA and frailty/pre-frailty in
European countries is high, involving nearly one-third
and two-thirds of the elderly, respectively. Clinical
OA is strongly associated with frailty and pre-frailty
in older adults. Although the association exists with
OA at any site, it is stronger with increasing number
of joints involved and when the affected joint is the
hip. Thus, the key is to implement preventive and
therapeutic measures in older persons with OA, espe-
cially early detection of frailty and the promotion of
physical exercise in all individuals and of fat weight
loss in obese individuals.
Significance and innovations
 OA and frailty are highly prevalent in the elderly
population in Europe, with an estimated frequency
that ranges between 19.7 % in Germany and 42.3 %
in Italy for OA and between 5.6 % in Germany and
Sweden and 15.4 % in UK for frailty.
 The odds of frailty is 2.96 (95 % CI:2.11-4.16) and
pre-frailty 1.54 (95 % CI:1.24-1.91) as high among OA
individuals than those without OA. The association
remains when OA of the knee, hip and hand joints
are considered separately, and is stronger in those
with increasing number of joints involved.
 This association might be considered when
designing appropriate intervention strategies for
OA management.
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